Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial)

BACKGROUND: Atopic dermatitis (AD) is associated with reduced skin microbial diversity and overgrowth of Staphylococcus (S.) aureus. However, the importance of S. aureus colonisation in the complex pathogenesis remains unclear and studies on the effect of anti-staphylococcal therapy in non-infected...

Descripción completa

Detalles Bibliográficos
Autores principales: Totté, Joan, de Wit, Jill, Pardo, Luba, Schuren, Frank, van Doorn, Martijn, Pasmans, Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580294/
https://www.ncbi.nlm.nih.gov/pubmed/28859690
http://dx.doi.org/10.1186/s13063-017-2118-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580294/
https://www.ncbi.nlm.nih.gov/pubmed/28859690
http://dx.doi.org/10.1186/s13063-017-2118-x

Ejemplares similares